Abstract

Aminobisphosphonates are a class of drugs effectively used for the management of pathologic skeletal conditions in people, most notably hormonally mediated osteoporosis and cancer-associated bone metastases. Based on their physicochemical properties, aminobisphosphonates concentrate within areas of active skeletal remodeling and exert protective bone biologic effects through the induction of osteoclast apoptosis. Given the similar mineral composition and cellular components of bone tissue shared among mammals, it would be expected that aminobisphosphonates should also be effective in managing malignant bone diseases in dogs and cats. The first half of this review article briefly summarizes the general properties of aminobisphosphonates including their pharmacology, mechanism of action, and potential adverse side effects. The second half of this review focuses on the clinical utility of aminobisphosphonates and measures of response in dogs and cats diagnosed with malignant skeletal tumors.

Original languageEnglish (US)
Pages (from-to)151-156
Number of pages6
JournalTopics in Companion Animal Medicine
Volume24
Issue number3
DOIs
StatePublished - Aug 2009

Keywords

  • antiresorptive agents
  • bone cancer pain
  • canine osteosarcoma
  • feline oral squamous cell carcinoma
  • malignant osteolysis

ASJC Scopus subject areas

  • Small Animals

Fingerprint

Dive into the research topics of 'Intravenous Aminobisphosphonates for Managing Complications of Malignant Osteolysis in Companion Animals'. Together they form a unique fingerprint.

Cite this